Actinium Pharmaceuticals EPS Diluted from Accounting Change (Quarterly) Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

1.32 +0.04 (+3.12%) USD | NYAM | Jan 21, 16:00

1.32 0.00 (0.00%) After-Hours: 20:00

View EPS Diluted from Accounting Change (Quarterly) for ATNM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Altimmune, Inc.	--
Aldeyra Therapeutics, Inc.	--
Avanos Medical, Inc.	--
NovaBay Pharmaceuticals, Inc.	--